These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
232 related items for PubMed ID: 6138775
1. Effects of agonists and antagonists of D1 and D2 dopamine receptors on self-stimulation of the medial prefrontal cortex in the rat. Ferrer JM, Sanguinetti AM, Vives F, Mora F. Pharmacol Biochem Behav; 1983 Aug; 19(2):211-7. PubMed ID: 6138775 [Abstract] [Full Text] [Related]
2. Depression of the monosynaptic reflex by apomorphine or bromocriptine is not mediated by D1/D2 receptors. Kamijo N, Nagao T, Ono H. Neuropharmacology; 1993 Aug; 32(8):777-83. PubMed ID: 8105410 [Abstract] [Full Text] [Related]
3. Characterization of dopamine receptors mediating inhibition of adenylate cyclase activity in rat striatum. Onali P, Olianas MC, Gessa GL. Mol Pharmacol; 1985 Aug; 28(2):138-45. PubMed ID: 2410769 [Abstract] [Full Text] [Related]
10. Opposite influences of dopaminergic receptor subtypes on penile erection. Zarrindast MR, Shokravi S, Samini M. Gen Pharmacol; 1992 Jul; 23(4):671-5. PubMed ID: 1356874 [Abstract] [Full Text] [Related]
11. Evidence that apomorphine and pergolide induce rotation in rats by different actions on D1 and D2 receptor sites. Herrera-Marschitz M, Ungerstedt U. Eur J Pharmacol; 1984 Feb 17; 98(2):165-76. PubMed ID: 6143675 [Abstract] [Full Text] [Related]
12. Opposing effects of dopamine D2 receptor stimulation on the spontaneous and the electrically evoked release of [3H]GABA on rat prefrontal cortex slices. Rétaux S, Besson MJ, Penit-Soria J. Neuroscience; 1991 Feb 17; 42(1):61-71. PubMed ID: 1677746 [Abstract] [Full Text] [Related]
13. Effects of D1 and D2 dopamine receptor stimulation on the activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine lesioned rats: D1/D2 coactivation induces potentiated responses. Weick BG, Walters JR. Brain Res; 1987 Mar 10; 405(2):234-46. PubMed ID: 2952219 [Abstract] [Full Text] [Related]
14. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation. Hu XT, White FJ. Synapse; 1992 Mar 10; 10(3):206-16. PubMed ID: 1532677 [Abstract] [Full Text] [Related]
15. Ventral tegmental area: site through which dopamine D2-receptor agonists evoke behavioural and electrocortical sleep in rats. Bagetta G, De Sarro G, Priolo E, Nisticò G. Br J Pharmacol; 1988 Nov 10; 95(3):860-6. PubMed ID: 2974741 [Abstract] [Full Text] [Related]
16. Differential modulation of striatonigral dynorphin and enkephalin by dopamine receptor subtypes. Jiang HK, McGinty JF, Hong JS. Brain Res; 1990 Jan 15; 507(1):57-64. PubMed ID: 1967976 [Abstract] [Full Text] [Related]
18. Characterization of dopamine autoreceptor and [3H]spiperone binding sites in vitro with classical and novel dopamine receptor agonists. Lehmann J, Briley M, Langer SZ. Eur J Pharmacol; 1983 Mar 18; 88(1):11-26. PubMed ID: 6133762 [Abstract] [Full Text] [Related]
19. Sulpiride alleviates the attentional impairments of rats with medial prefrontal cortex lesions. Passetti F, Levita L, Robbins TW. Behav Brain Res; 2003 Jan 06; 138(1):59-69. PubMed ID: 12493630 [Abstract] [Full Text] [Related]
20. Effects of DA-1- and DA-2-dopamine antagonists on apomorphine-induced inhibition of peripheral sympathetic neurotransmission. Hietala J. J Auton Pharmacol; 1988 Dec 06; 8(4):297-302. PubMed ID: 2855331 [Abstract] [Full Text] [Related] Page: [Next] [New Search]